A Study to Investigate the Next-day Residual Effects of TS-142 in Healthy Elderly Subjects

NCT05819710 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

43

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

DRUG: TS-142
DRUG: TS-142
DRUG: Zopiclone
DRUG: Placebo

Sponsor

Taisho Pharmaceutical Co., Ltd.